This document discusses emesis and various drugs used to treat nausea and vomiting. It begins by describing the protective reflex of emesis and the phases of the vomiting process. It then outlines the receptors involved in emesis and lists several classes of emetic and antiemetic drugs, including their mechanisms of action and uses. Examples discussed include ondansetron, aprepitant, metoclopramide, prochlorperazine, and dexamethasone. The document provides details on the pharmacokinetics, therapeutic uses, and adverse effects of many antiemetic medications.
Hello friends. In this PPT I am talking about antiepileptic drugs. If you like it, please do let me know in the comments section. A single word of appreciation from you will encourage me to make more of such videos. Thanks. Enjoy and welcome to the beautiful world of pharmacology where pharmacology comes to life. This video is intended for MBBS, BDS, paramedical and any person who wishes to have a basic understanding of the subject in the simplest way.
Hello friends. In this PPT I am talking about antiepileptic drugs. If you like it, please do let me know in the comments section. A single word of appreciation from you will encourage me to make more of such videos. Thanks. Enjoy and welcome to the beautiful world of pharmacology where pharmacology comes to life. This video is intended for MBBS, BDS, paramedical and any person who wishes to have a basic understanding of the subject in the simplest way.
Basic principles of chemotherapy/ AMAs covers definition, history of AMAs development, principles of AMAs, problems associated with AMAs, failure of therapy with examples.
My all and slides mostly try to simplify pharmacy knowledge. Any time you are free to connect me. It's my pleasure to help you to get simplified pharmacy concepts. You may suggest topics needs to simplify the terminolog
Summary of thyroid and antithyroid drugs
-Introduction
-Synthesis
-Pharmacological Action
-Mechanism of action
-Drugs in Hypothyroidism
-Thyroid Inhibitors
-Drugs in Hyperthyroidism
Immunosuppressant are drugs or medicines that lower the body's ability to reject a transplanted organ. Another term for these drugs is anti-rejection drugs. There are 2 types of immunosuppressants: Induction drugs: Powerful antirejection medicine used at the time of transplant.
Basic principles of chemotherapy/ AMAs covers definition, history of AMAs development, principles of AMAs, problems associated with AMAs, failure of therapy with examples.
My all and slides mostly try to simplify pharmacy knowledge. Any time you are free to connect me. It's my pleasure to help you to get simplified pharmacy concepts. You may suggest topics needs to simplify the terminolog
Summary of thyroid and antithyroid drugs
-Introduction
-Synthesis
-Pharmacological Action
-Mechanism of action
-Drugs in Hypothyroidism
-Thyroid Inhibitors
-Drugs in Hyperthyroidism
Immunosuppressant are drugs or medicines that lower the body's ability to reject a transplanted organ. Another term for these drugs is anti-rejection drugs. There are 2 types of immunosuppressants: Induction drugs: Powerful antirejection medicine used at the time of transplant.
Introduction TO VOMITING,Pathophysiology of vomiting,Emetics,Anti emetics,classification,pharmacology,Drug treatment in selected circumstances FOR EMETICS were included.
Emetics & Anti-emetics presentation for pharmacy studentsLokesh Patil
Emetics and antiemetics are drugs used to induce and prevent vomiting, respectively. Emetics, such as ipecac syrup and apomorphine, stimulate the vomiting center in the brain or irritate the stomach lining to induce vomiting, often used in cases of poisoning. Antiemetics, including drugs like ondansetron, metoclopramide, and promethazine, work by blocking neurotransmitters like serotonin, dopamine, and histamine, which are involved in triggering the vomiting reflex. They are commonly used to treat nausea and vomiting caused by conditions such as motion sickness, chemotherapy, and postoperative recovery. Understanding the mechanisms and applications of these drugs is crucial for effectively managing emesis in various clinical scenarios.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
2. EMESIS
•Protective reflex - to get rid the stomach and
intestine of toxic substances and prevent their
further ingestion.
Pre-ejection phase: Gastric relaxation &
retroperistalsis
Retching: Rhythmic action of respiratory muscles
preceding vomiting and consisting of contraction of
abdominal and intercostal muscles and diaphragm
against a closed glottis
Ejection: intense contraction of the abdominal
muscles and relaxation of the upper
esophageal sphincter
6. EMETICS
According to site of action:
a.Centrally acting: Apomorphine &
Morphine
b.Peripherally acting: Mustard,
Potassium tartrate (tartar emetic)
and hypertonic sodium chloride
c.Both: Ipecacuanha
7. APOMORPHINE
D2 AGONIST
• Given SC/IM -6mg
Causes vomiting within 15 min
Vomiting is often accompanied by sedation
Should not be used if respiration is depressed
Large doses often produce restlessness, tremors, occasionally
convulsions
Sometimes may cause hypotension, syncope and coma
8. Emetics –Peripherally acting
Mustard:
Volatile oil
safe and easily available
Dose -1 tsp inwater
Sodium chloride:
Given orally
Withdraws fluid from the cells lining the stomach
causes irritation which causes reflex emesis
10. LIST OF DRUGS INDUCE
VOMITING
Anticancer drugs
Amiodarone
Apomorphine
Chloroquine, quinine
Diltiazem
Emetine
Ergot derivatives
Erythromycin, tetracyclines
Fluroquinolones
Metronidazole
11.
12. ANTICHOLINERGICS
HYOSCINE
Dosage: 0.2-0.4 mg oral, i.m.
Most effective drug for motion sickness
But action is brief; & sedation & other anticholinergic
side-effects
MOA – Block cholinergic NT in the vestibular-emetic
centre pathway not useful for vomiting other than
due to motion sickness
TTDS – 1.5 mg over 3 days; applied behind pinna,
good efficacy and minimal side effects
DICYCLOMINE – 10-20 mg P/O For prophylaxis of
motion sickness and morning sickness; no
teratogenicity seen now; blocks M receptors 12
13. H1 ANTIHISTAMINES
13
PROMETHAZINE,
DIPHENHYDRAMINE,
DIMENHYDRINATE –
• Motion sickness for 4-6 hrs
• ADE – sedation & mouth dryness
++
Combined with metoclopramide, it
abolishes its extra pyramidal side
effects combination is useful in
motion sickness (more efficacy,
less side effects)
DOXYLAMINE –
• A sedative H1-antihistamine + anti
cholinergic
Combined with pyridoxine for early
pregnancy morning sickness
Pk - Oral absorption – slow
ADE – dry mouth, drowsiness,
vertigo & Abd. Upset
Dose - 10-20 mg at bedtime is the
dose frequency can be
increased to thrice daily if needed
CYCLIZINE & MECLIZINE –
• Less sedative & less
anticholinergic side-effects
Meclizine = longer acting, protects
against sea sickness for ~ 24 hrs.
CINNARIZINE –
• Anti-vertigo drug in motion
sickness
Inhibits Ca++ influx from
endolymph into vestibular sensory
cells regain labyrinthine reflexes
no vertigo / emesis
14. GENERAL POINTS ABOUT H1
BLOCKERS IN EMESIS Rx -
First choice in motion sickness
Taken ½ - 1 hr before journey; like all
anti-motion sickness drugs
Once motion sickness starts, it is difficult
to control higher/parenteral doses
required
Due to some teratogenic potential, avoid
them if possible
Other modalities – reassure & diet
adjustment
17-05-2023 14
15. NEUROLEPTICS
Potent anti-emetics
Block D2 receptors in CTZ + antimuscarinic + antiH1
properties
Broad spectrum anti-emetic action
Drug-induced & post-GA nausea/vomiting
Gastroenteritis-, uraemia-, liver disease- & migraine-
induced vomiting
Malignancy- & chemotherapy-induced vomiting
Radiation sickness vomiting (less effective)
Hyper emesis gravid arum
Less effective in motion sickness as vestibular
pathway does not involve DA
17-05-2023 15
16. PROCHLORPERAZINE
D2 – blocker phenothiazine labyrinthine
suppressant
Antivertigo & antiemetic actions
Useful in vertigo-associated & chemotherapy-
induced nausea/vomiting
ADE: Extra pyramidal side-effects & muscle
dystonia
Antiemetic dose << anti-psychotic dose
Not given till cause of emesis is diagnosed
17-05-2023 16
17. PROKINETIC AGENTS -
Promote gastrointestinal transit and speed gastric
emptying by enhancing coordinated propulsive
motility.
Metoclopramide
Domperidone/Tegaserod
Cisapride/Mosapride
METOCLOPRAMIDE
GIT ACTIONS: Speeds gastric emptying
decreases transit time in stomach + LES tone is
increased
CNS: On CTZ, it anti-emesis
Pk – crosses placenta, actions last 4-6 hrs.
17-05-2023 17
18. Dopamine
5-HT4 agonism
5-HT3
antagonism
Inhibitory transmitter in GIT
• Delay gastric emptying when food is
present in stomach
• Cause gastric dilatation and LES
relaxation attending nausea and
vomiting.
• G.i.t. to enhance ACh release from
myenteric motor neurons
• Gastric hurrying and LES tonic
• 5-HT3 receptors present on inhibitory
myenteric interneurones and in NTS/
CTZ.
19. ADE
Sedation, muscle
dystonia in children,
loose stools, long term
use parkinsonism,
galactorrhoea,
gynecomastia
USES
1) Antiemetic: migraine,
radiation sickness,
postoperative & drug-
induced emesis;
2) gastro kinetic:
duodenal intubation,
emergency GA, Relieve
gastric stasis due to
vagotomy/DM;
3) Dyspepsia &
hiccoughs;
4) GERD: With PPIs &
H2-blockers
17-05-2023 19
20. • D 2 antagonist
• Chemically related to haloperidol but pharmacologically related
to metoclopramide
• Has lower ceiling antiemetic and prokinetic actions
• Poorly crosses BBB
• Rare extra pyramidal side effects
• Absorbed orally, but bioavailability is only 15% due to first pass
metabolism
• Completely metabolized and excreted in urine
• t ½ is 7.5hr
Domperidone
Cont…
21. Cisapride
5-HT4 agonistic (which promotes ACh release from
myenteric neurons) and 5-HT3 antagonistic (minor)
action in the myenteric plexus.
Little antiemetic property, because it lacks D2
receptor antagonism
G a s t r i c e m p t y i n g i s a c c e l e r a t e d
LES tone is improved, esophageal peristalsis
augmented
Enteric neuronal activation via 5-HT4 receptor also
promotes cAMP-dependent Cl– secretion in the
colon, increasing water content of stool
Devoid of action on CTZ and does not produce
extrapyramidal symptoms
Primary indication of cisapride has been GERD
22. Ventricular arrhythmias and death, mainly
among patients who took CYP3A4
inhibitors like azole antifungals,
macrolide antibiotics, antidepressants,
HIV protease inhibitors,.
At high concentrations, cisapride blocks
delayed rectifying K+ channels in heart—
prolongs Q-Tc interval and predisposes to
torsades de pointes/ventricular fibrillation
Itopride
23. A 55-year-old woman with type 1 diabetes of 40
years’ duration complains of severe bloating and
abdominal distress, especially after meals.
Evaluation is consistent with diabetic
gastroparesis. Which of the following is a
prokinetic drug that could be used in this
situation?
(A) Alosetron
(B) Cimetidine
(C) Loperamide
(D) Metoclopramide
(E) Sucralfate
25. 5HT3 ANTAGONISTS
Role of Serotonin in EMESIS
Vagal,spinal visceral afferents send
impulses to
NTS and CTZ.
Extrinsic primary
afferent neurones (PAN) of the
enteric nervous
system (ENS).
Release of 5-HT from
Enterochromaffin cells
5-HT spilled into
circulation
reach CTZ via
vascular route
Substance P
Bradykinin
Neurokinin
Cannabinoid
Opioid
27. PK
Absorbed well
Rapid onset of action
METABOLISM T1/2
Ondansetron CYP1A2, CYP2D6, and
CYP3A4
3-6 hours
Granisetron-
10times more
potent
CYP3A4 6-9 hours
Dolasetron Plasma carbonyl
reductase
to its active metabolite,
hydrodolasetron.CYP2
D6 and CYP3A4
7-9 hrs
Palonosetron CYP2D6, but also by
CYP3A4 and CYP1A2.
40 hrs
28. CLINICAL USES
Prevention and treatment of
Chemotherapy-induced nausea and
vomiting- Acute
Palanosetron even for delayed
Postoperative nausea and vomiting in
adults and children
Drug overdosage, g.i. disorders,
uraemia
Neurological injuries
29. ADVERSE EFFECTS
Well tolerated
Headache and dizziness.
Mild constipation and abdominal discomfort
occur in few patients.
Hypotension, bradycardia, chest pain and
allergic reactions are
PALANOSETRON – Additive Q-T
prolongation can occur when given
Cisapride, moxifloxacin, erythromycin, anti-
psychotics and antidepressants
30. NEUROKININ1 RECEPTOR
ANTAGONISTS
Substance P from
emetogenic stimuli
ActIvation of NK1 Receptor
at CTZ and NTS
1. Aprepitant
2. Rolapitant
3. Netupitant
DELAYED VOMITING
Always with SETRONS and
DEXAMETHASONE
31. APREPITANT
• Extensively
bound to plasma
proteins (>95%)
• Metabolized
primarily by
hepatic CYP3A4
• Excretion-
Stools
• t1/2 is 9–13hrs
ROLAPITANT
• t1/2 at about
180 h.
• CYP3A4 to form
an active
metabolite, M19
(C4-
pyrrolidinehydro
xylated
• rolapitant).
• Eliminated
mainly via the
hepatic/biliary
route.
• CYP2D6
INHIBITORS
NETUPITANT
• T1/2-~ 80 h;
• extensively
metabolized by
CYP3A4 (major)
and CYP2C9
and CYP2D6
• (minor) to active
metabolites.
• Urine and
faeces
32. THERAPEUTIC USES A/E
CINV,prior to highly
emetogenic drugs
Neutropenia,
Hiccups,
Decreased appetite
Dizziness
Rise in liver enzymes.
33. CANNABINOIDS
Dronabinol, Nabilone
Δ9 Tetrahydrocannabinol - Cannabis indica
Moderately emetogenic chemotherapy.
CB1 subtype of cannabinoid receptors
located on neurones in the CTZ and/ or the
vomiting centre itself.
Inhibits proemetic effects of endogenous
compounds such as dopamine and
serotonin
34. • Highly lipid soluble
• Onset – 2 hr
• Extensive first-pass
metabolism with limited
systemic bioavailability
after single doses (only
• 10%–20%).
• Faeces
• Large Vd
.
• CNS-central
sympathomimetic activity.
This can lead to
palpitations, tachycardia,
vasodilation, hypotension,
and conjunctival injection
(bloodshot eyes).
• Abstinence syndrome
(irritability, insomnia, and
restlessness)
• Marijuana-like “highs”
Prophylactic agent in patients
receiving cancer
chemotherapy when other
antiemetic medications are
not effective.
AIDS related cachexia